Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer - Wikidata - wikimedia - TriplyDB

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

http://www.wikidata.org/entity/Q24616117

about

Integrative annotation of variants from 1092 humans: application to cancer genomics MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes Advances in genetics: widening our understanding of prostate cancer Mass Spectrometry-Based Proteomics for Investigating DNA Damage-Associated Protein Ubiquitylation Cullin 3 Ubiquitin Ligases in Cancer Biology: Functions and Therapeutic Implications Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer Clonal origin and spread of metastatic prostate cancer Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer Stem cells in genetically-engineered mouse models of prostate cancer Mediator kinase module and human tumorigenesis Physiology of the read-write genome Quantifying ubiquitin signaling Minireview: Conversing with chromatin: the language of nuclear receptors The Mediator complex: a central integrator of transcription Mutational signatures: the patterns of somatic mutations hidden in cancer genomes The mutational landscape of prostate cancer Functional genomics lead to new therapies in follicular lymphoma SWI/SNF chromatin remodeling complexes and cancer Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies Quo vadis: advanced prostate cancer-clinical care and clinical research in the era of multiple androgen receptor-directed therapies Emerging patterns of somatic mutations in cancer Interplay between genomic alterations and androgen receptor signaling during prostate cancer development and progression Targeting the adaptive molecular landscape of castration-resistant prostate cancer Structural basis of high-order oligomerization of the cullin-3 adaptor SPOP Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution.Assembly of methylated KDM1A and CHD1 drives androgen receptor-dependent transcription and translocation Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.Integrative clinical genomics of advanced prostate cancer.The importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance Interplay of estrogen receptors and FOXA factors in the liver cancer Trial Watch: Proteasomal inhibitors for anticancer therapy The roles of chromatin-remodelers and epigenetic modifiers in kidney cancer Dysregulation of ubiquitin ligases in cancer MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer Inactivating CUX1 mutations promote tumorigenesis A combination of genetic and biochemical analyses for the diagnosis of PI3K-AKT-mTOR pathway-associated megalencephaly Notch pathway activation is essential for maintenance of stem-like cells in early tongue cancer

P2860

Q22065599-F8A481B7-7601-4DD9-B85A-E057C877CBA8 Q24304423-454EAFBB-5B45-4A57-B992-80ADFECFAAAB Q24596715-34D10CAD-D50A-4CBF-8705-94D0381AC695 Q26740628-21EC1C19-CD23-4470-A1CA-98A7384E9E21 Q26744515-4E942304-C684-4840-BE6C-B1A98818F2AC Q26747274-F51F3698-81CD-4718-8EBB-F42AC931F56C Q26751237-53CA6496-C29B-4164-B70E-191C9C5AC1C6 Q26752873-7FA0E085-F839-4A77-B9AE-8D9BD3970514 Q26777310-7FD1A8E5-60AB-4B56-BA9B-9F65893B6DAF Q26784057-15F3D6AE-263F-4066-80AB-3CEC974144BE Q26800203-1C9D0FFE-C3F7-4CFC-ACE9-E3DFC5663356 Q26822420-FAB1E522-F216-45DA-ABF9-3825ABBCE92E Q26823466-4A03656A-DD2F-40EC-AF56-E7CDBBD6BB39 Q26829103-3A9E4487-9647-4BE7-8738-29829FFA7B14 Q26849595-E363B9D5-9E15-4467-A1CE-13A3E6DAAD1E Q26850125-97846E82-FD64-4D7E-9759-E729C19BFEEE Q26851631-6801B79C-E849-419A-86BF-0EE33BC6A805 Q26852415-87CC4AFB-62D5-4C6F-9094-04E20982C977 Q26998657-A5146201-30E9-4915-885D-1A02574BC9C7 Q27001399-B7F9C6F0-E864-4703-877C-1BF56B60D4B8 Q27007065-7F6F138E-6322-4D8B-9361-AB2D485ECC1D Q27011642-EDBEBAF1-8E31-4775-80D5-17BBF77F53BC Q27014126-297039DD-168D-4BF1-9AF7-A9DE90484037 Q27022288-71CFEFF4-4FB7-4794-9814-84F9BEBE84D7 Q27022821-3E8F0F45-E392-4A58-BB49-A349B1AF7B38 Q27685443-CF66A9D7-CA41-40FF-9E26-3D1D4549C7E0 Q27690285-0D9D37D9-1323-4E0C-B812-C4529CB3998D Q27703586-1E3C6C37-F73F-4863-AD65-25FF8CFD04BE Q27853005-A279DF13-D886-4C71-825C-D570FF841FB7 Q27853170-91C97F12-61E6-4C1F-8C12-10CC9860ED3F Q28076745-CB1881B8-EBDA-4464-BC45-5DF0B39BCE21 Q28081337-6326E881-5429-488C-AAEA-1F6714AE9FA4 Q28082910-8E9DE438-109D-4820-A48C-F102511E2FEF Q28083152-5E1F6BC9-DC24-4416-9C1F-9138A2AF951C Q28086796-39EB82E9-8417-4E9F-B1B8-247A62FFC849 Q28260148-22139044-C62B-4190-87B4-F7BA1C221283 Q28268284-BD24B755-8E2F-45FA-AC73-A8C4C157D935 Q28303563-569503D8-13EE-4E96-A5EA-5D2E36F27C4C Q28468603-C28F2B06-C6AC-446A-82F6-34E0A6EEACCF Q28468650-BCE166EC-ED09-40EB-9FB6-B438582B7524

P2860

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

http://www.wikidata.org/entity/Q24616117

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

@ast

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

@en

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

@nl

type

label

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

@ast

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

@en

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

@nl

prefLabel

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

@ast

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

@en

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

@nl

P1433

Q24616117-549E160E-B775-4409-8857-27999B5EB0BB

P1476

Q24616117-32F420DF-9ECD-4D6E-A814-EDE33221BD0F

P2093

Q24616117-04BAF616-9E85-460A-B3AB-E544D5BCBEB1

Q24616117-05216A31-AB00-4979-8766-127C80F9764C

Q24616117-05C1C70A-15F7-434C-9B06-0DB6EA511C53

Q24616117-18EA914F-F751-4DE9-9CFB-60626E682B9D

Q24616117-1B72F84F-BA3E-48AE-A4B6-304B578825D3

Q24616117-360E6BC3-E166-4CD3-8F9A-EC37EABAF25C

Q24616117-3A9AADAD-5917-4DB9-BBC5-5969D7203239

Q24616117-3C963B20-1398-481E-AF94-A2494DF8981F

Q24616117-4A8B3D6B-B12B-41C1-A5C9-63EC0F7E59C6

Q24616117-6810A4AE-8514-4B25-B666-54C67D8A50D3

P2860

Q24616117-08FCB2DB-9E5A-4E73-9B1E-7B6E44A35F50

Q24616117-0C8A14DA-18BC-4A48-86F7-9D3FE9B8EB3B

Q24616117-14173A0D-FC80-465F-B25D-A364E16725C9

Q24616117-1765EA2A-F89A-4D27-B3F0-F0FF14ABFC45

Q24616117-272172E1-BABC-42F8-8795-9EB3D8E2EFF0

Q24616117-277983B6-ECF9-4669-A668-50B2B3FC75B4

Q24616117-27CFCD27-4850-4775-9FBF-10F6449B4BAE

Q24616117-28A8121E-E38D-44C5-9238-22B5C68FB44A

Q24616117-2906ECE2-AB4F-453E-9FB9-E3EEB7C3A359

Q24616117-2C9393A9-15D9-4B5E-BC2E-1F742A8A3A8E

P2888

Q24616117-4D9CC9D0-F1C1-4A5F-A8DE-83B184F2EC76

P304

Q24616117-6CCE48B4-EF4D-4DA8-989B-FFE31150AE12

P31

Q24616117-BBD73BB2-B49C-403E-90E1-1B26E70DDD58

P3181

Q24616117-482E3127-BB8E-4289-9DEF-E40430343CE1

P356

Q24616117-64B71431-7963-42A7-8A68-7AAD0C4FA803

P407

Q24616117-74518733-D947-427E-9ECA-075C5DB2E772

P433

Q24616117-380D2ABA-EE25-42ED-A3F8-80834D9EC9AB

P478

Q24616117-53506B04-9072-4177-97F1-0B445B288645

P50

Q24616117-1D24E7F4-B5FB-4AF5-8EF1-F6B1CDCFD03E

Q24616117-1FC192BA-A382-4653-A57A-62B8A5D5956D

Q24616117-246B90AD-E449-4442-84E5-D7DA28E13151

Q24616117-2D14FB44-A2F1-4027-8798-C1620F72A96C

Q24616117-3102CDF4-C78B-4E88-B3AA-7DEDDB1B6514

Q24616117-3843E592-DF4E-4677-BFB8-7B7839246FAD

Q24616117-3BE8C429-38DF-47AD-9AF2-D45520A81272

Q24616117-4325DF2B-A417-4B5A-9969-942174EC693C

Q24616117-4A04CD63-47E2-4720-8172-F4D670E57D54

Q24616117-4FA33F7C-5D34-4E4B-B12D-195C4A535865

P577

Q24616117-09A570EF-AF69-4D84-8F8F-E8B05E5CE1C3

P5875

Q24616117-B871EAD1-AF65-433C-A987-8B8444218C0A

P6179

Q24616117-08861285-C7A8-485B-9361-D9A88B3F2FFB

P698

Q24616117-869675CF-2D7B-40ED-92B7-1F3C7BC3FBD4

P932

Q24616117-B9EB501F-D076-4062-B451-4A887A36BD64

P3181

P356

P1433

Nature Genetics

P1476

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

@en

P2093

Alex H Ramos

http://www.w3.org/2001/XMLSchema#string

Andrey Sivachenko

http://www.w3.org/2001/XMLSchema#string

Ashutosh K Tewari

http://www.w3.org/2001/XMLSchema#string

Colm Morrissey

http://www.w3.org/2001/XMLSchema#string

Holger Moch

http://www.w3.org/2001/XMLSchema#string

Juan Miguel Mosquera

http://www.w3.org/2001/XMLSchema#string

Karen Sheikh

http://www.w3.org/2001/XMLSchema#string

Kyung Park

http://www.w3.org/2001/XMLSchema#string

Michael S Lawrence

http://www.w3.org/2001/XMLSchema#string

Michelle C Redman

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1)

Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1

A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression

SOX9 interacts with a component of the human thyroid hormone receptor-associated protein complex.

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

dbSNP: the NCBI database of genetic variation

miRBase: integrating microRNA annotation and deep-sequencing data

Ongoing and future developments at the Universal Protein Resource

The genomic complexity of primary human prostate cancer

P2888

P304

685-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

577587

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NG.2279

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

Candace Guiducci

Kristian Cibulskis

Nicolas Stransky

Elizabeth Nickerson

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225049535

http://www.w3.org/2001/XMLSchema#string

P6179

1020829840

http://www.w3.org/2001/XMLSchema#string

P698

22610119

http://www.w3.org/2001/XMLSchema#string

P932

3673022

http://www.w3.org/2001/XMLSchema#string